US Patent Issued to Redona Therapeutics on June 23 for "Compounds targeting RNA-binding proteins or RNA-modifying proteins" (Massachusetts Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,491, issued on June 23, was assigned to Redona Therapeutics Inc. (Watertown, Mass.).

"Compounds targeting RNA-binding proteins or RNA-modifying proteins" was invented by Anna M. Ericsson (Shrewsbury, Mass.), Shomir Ghosh (Brookline, Mass.) and Darren Martin Harvey (Acton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a compound represented by Formula (I): or a pharmaceutically acceptable salt thereof, compositions comprising the same and methods of preparing and using the same. The variables are described herein."

The patent was filed on March 2, 2021, under Application No. 17/908,576.

*For further information, incl...